NCT02243332

Brief Summary

The purpose of this small, pilot study is to evaluate a novel device that uses neuromuscular electrical stimulation to assist quadriceps muscles as a user walks. This study will involve use of this device on individuals with patellofemoral pain, a relatively common injury among active people, to see if quadriceps stimulation could mitigate disparities in quadriceps activation timing that may indirectly lead to knee pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

September 12, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 17, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

June 27, 2017

Status Verified

June 1, 2017

Enrollment Period

2.5 years

First QC Date

September 12, 2014

Last Update Submit

June 26, 2017

Conditions

Keywords

KneePainJointRehabilitationPatellofemoral Pain SyndromeAnterior Knee Pain SyndromeKnee PainQuadriceps

Outcome Measures

Primary Outcomes (1)

  • Measured Quadriceps Musculature Co-Contraction

    Electromyographic (EMG) readings of vastus lateralis and vastus medialis contraction patterns will be taken after four six-minute walk tests (6MWTs) to evaluate any short-term changes in co-contraction. 6MWT #1: Without interventional device being worn; 6MWT #2: With interventional device being worn, but unpowered; 6MWT #3: With interventional device being worn and operational; 6MWT #4: Without interventional device being worn The time period in which a partipant will be involved is not expected to exceed 90 minutes.

    20, 40, 60, 80 minutes from start of single-day testing

Secondary Outcomes (2)

  • Anterior Knee Pain

    20, 40, 60, 80 minutes from start of single-day testing

  • Device Joint Model Accuracy

    20, 40, 60, 80 minutes from start of single-day testing

Study Arms (1)

Device (rehabilitation assistance)

EXPERIMENTAL

Device: KneeStim mobile rehabilitation assistance device

Device: KneeStim mobile rehabilitation assistance device

Interventions

KneeStim is a neuromuscular electrical stimulation (NMES) device that integrates motion-tracking hardware like three-axis accelerometers and a real-time operating system to enable quadriceps muscle stimulation in time with user gait. It is a completely non-invasive device that looks like a light brace and fastens to the user's quadriceps and gastrocnemius muscles. The end goal of this device is to assist with muscle re-strengthening and re-education during a user's everyday activities.

Also known as: KneeStim
Device (rehabilitation assistance)

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-40 years
  • Symptomatic PFPS on Patella Glide Test, Patella Tilt Test, and Patellar Apprehension Test.

You may not qualify if:

  • Rheumatoid arthritis or inflammatory arthritis as assessed by licensed physician
  • Use of walking aids other than a cane more than 50% of the time in ambulation
  • Diagnosed knee disorder other than patellofemoral syndrome
  • Pacemaker use, unstable angina, or decompensated heart failure
  • Knee replaced in preceding 12 months or replacement planned within 6 months
  • Moderate to severe dementia
  • Pregnancy (self report)
  • Altered sensation at the knee such that the patient is unable to perceive the presence of pinprick.
  • Use of intra-articular viscosupplementation or steroid injection within preceding 2 months.
  • Use of chronic anticoagulation medication.
  • Movement-limiting pain in the back, hip, ankle, or foot of either lower limb.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Developmental Motor Control Lab; University of Texas at Austin

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

Patellofemoral Pain SyndromePain

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lisa Griffin, Ph.D.

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2014

First Posted

September 17, 2014

Study Start

September 1, 2014

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

June 27, 2017

Record last verified: 2017-06

Locations